» Articles » PMID: 874640

Pulmonary Ultrastructure After Oral and Intravenous Dosage of Paraquat to Rats

Overview
Journal J Pathol
Specialty Pathology
Date 1977 Apr 1
PMID 874640
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Paraquat was administered to rats by gavage or intravenously at doses which were approximately equitoxic (680 mu. moles/kh and 65 mu. moles/kg respectively) and the lungs examined by light and electron microscopy at intervals up to 48 hours. No significant changes were observed in alveolar endothelial cells at any of the time intervals studied. After intravenous administration the first ultrastructural changes were observed at 4 hr in the type I cells which were less electron dense and contained few organelles. At 8 hr these lesions were more marked and in some places the basement memebrane was denuded. Type II cells were also showing damage to mitochondria and loss of microvilli. After oral dosing, the type and sequence of changes was similar but the first changes were not seen until 22 hr. Intravenous injection of 0-03 micron carbon particles 1 hr before killing showed no significant leakage from the alveolar endothelium. This study provides no morphological evidence that the oedema of the lung caused by paraquat in rats is due to damage to endothelial cells. It appears that, following dosing by the two routes, the difference in interval between dosing and the development of lesions is due to the accumulation of paraquat. Lesions in type I cells therefore occurred when a certain concentration of paraquat is known to be present in the lung. It is suggested that a prime compartment into which paraquat is accumulated is the alveolar epithelial cell.

Citing Articles

Thoracic radiographic features of fatal paraquat intoxication in eleven dogs.

Kuo Y, Lin L, Li Y, Chen K Vet Q. 2021; 41(1):217-225.

PMID: 34223806 PMC: 8300932. DOI: 10.1080/01652176.2021.1950945.


Increased plasma prothrombin time is associated with poor prognosis in patients with paraquat poisoning.

Hu X, Guo R, Chen X, Chen Y J Clin Lab Anal. 2018; 32(9):e22597.

PMID: 29943421 PMC: 6817204. DOI: 10.1002/jcla.22597.


Liver X Receptor Agonist TO901317 Attenuates Paraquat-Induced Acute Lung Injury through Inhibition of NF-B and JNK/p38 MAPK Signal Pathways.

Hu X, Shen H, Wang Y, Zhao M Biomed Res Int. 2017; 2017:4652695.

PMID: 28480221 PMC: 5396433. DOI: 10.1155/2017/4652695.


Paraquat induces irreversible actin cytoskeleton disruption in cultured human lung cells.

Cappelletti G, Incani C, Maci R Cell Biol Toxicol. 1994; 10(4):255-63.

PMID: 7895154 DOI: 10.1007/BF00756765.


Intrabronchial instillation of paraquat in rats: lung morphology and retention study.

Wyatt I, Doss A, ZAVALA D, Smith L Br J Ind Med. 1981; 38(1):42-8.

PMID: 7470404 PMC: 1008797. DOI: 10.1136/oem.38.1.42.